Prescription drug · BLA
Lumvoa (Veligrotug) NDC 85166-001
Veligrotug 50 mg/mL · Injection · Intravenous · Viridian Therapeutics, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 85166-001-01 | 85166000101 | 1 VIAL, SINGLE-DOSE in 1 CARTON (85166-001-01) / 10 mL in 1 VIAL, SINGLE-DOSEMarketed from Jun 26, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lumvoa
- Generic name (nonproprietary)
- veligrotug
- Active ingredients
- Veligrotug — 50 mg/mL
- Dosage form
- Injection
- Route
- Intravenous
- Labeler
- Viridian Therapeutics, Inc.NDC labeler code 85166
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 761530
- Marketing start
- Listing expires
- Identifiers
- Product ID 85166-001_b2e929f4-7a8c-4289-98aa-4f042e645c3aSPL ID b2e929f4-7a8c-4289-98aa-4f042e645c3aSPL set ID 11bc286a-5411-45af-af3f-69ad38efb610RxCUI 2746009, 2746016UNII Z9U2SS9ZC8UPC 0385166001017
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N485166000101followed by a unit qualifier and the quantityPackage 85166-0001-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
LUMVOA is indicated for the treatment of thyroid eye disease regardless of thyroid eye disease activity or duration. LUMVOA is an insulin-like growth factor-1 receptor inhibitor indicated for the treatment of thyroid eye disease regardless of thyroid eye disease activity or duration. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 85166-001
- What is NDC 85166-001?
- 85166-001 is the product NDC for Lumvoa (veligrotug), Veligrotug 50 mg/mL injection, listed with the FDA by Viridian Therapeutics, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Lumvoa (Veligrotug).
- What is the active ingredient?
- Veligrotug.
- Who is the labeler?
- Viridian Therapeutics, Inc., NDC labeler code 85166. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Lumvoa?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.